The group's principle activity is to provide recombinant synthesis of compounds for anticoagulation market and associated arenas. The group’s services include pharmaceutical anticoagulation drug development, bulk manufacturing/ fermentation processes, medical device coating and infectious disease/cancer drug discovery. The group operates from United States.
